Nalbuphine HCL (Nalbuphine hydrochloride) is a narcotic pain reliever used to treat moderate to severe pain.Nubain is also used for treating pain just after surgery or childbirth.

The global Nalbuphine HCL market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Nalbuphine HCL volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nalbuphine HCL market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nalbuphine HCL in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nalbuphine HCL manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Acme
Dr Reddy's
Glenmark
Global Pharmaceuticals
HOSPIRA
Humanwell
Incepta Pharmaceuticals
Manusaktteva
Opsonin
Sami
Squarepharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Adult
Children

Segment by Application
Hospital
Pharmacy
Others